Skip to content
naulon
Not checkedNot checked for notices yet.

Trends in utilization of lipid- and blood pressure-lowering agents and goal attainment among the U.S. diabetic population, 1999-2008

Kuznik Andreas, Mardekian Jack

Cardiovascular Diabetology · 2011

doi:10.1186/1475-2840-10-31 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

<p>Abstract</p> <p>Background</p> <p>For patients with diabetes, clinical practice guidelines recommend treating to a low-density lipoprotein cholesterol (LDL-C) goal of <2.59 mmol/L (100 mg/dL) and a blood pressure (BP) target of <130/80 mmHg. This analysis assessed recent trends in the utilization of lipid-lowering and BP-lowering agents, as well as LDL-C and BP goal attainment, in the U.S. adult diabetic population.</p> <p>Methods</p> <p>9,167 men and nonpregnant women aged ≥20 years were identified from the fasting subsample of the 1999-2008 National Health and Nutritional Examination Survey. Diabetes was identified in 1,214 participants by self report, self-reported use of insulin or oral medications for diabetes, or fasting glucose ≥6.99 mmol/L (126 mg/dL).</p> <p>Results</p> <p>The prevalence of diagnosed or undiagnosed diabetes increased significantly over the past decade, from 7.4% in 1999-2000 to 11.9% in 2007-2008 (<it>P </it>= 0.0007). During this period, the use of lipid-lowering agents by participants with diabetes increased from 19.5% to 42.2% (<it>P </it>< 0.0001), and the proportion at LDL-C goal increased from 29.7% to 54.4% (<it>P </it>< 0.0001). Although there was a significant increase in antihypertensive medication use (from 35.4% to 58.9%; <it>P </it>< 0.0001), there was no significant change in the proportion of participants at BP goal (from 47.6% to 55.1%; <it>P </it>= 0.1333) or prevalence of hypertension (from 66.6% to 74.2%; <it>P </it>= 0.3724).</p> <p>Conclusions</p> <p>The proportion of diabetic individuals taking lipid- and BP-lowering agents has increased significantly in recent years. However, while there has been a significant improvement in LDL-C goal attainment, nearly one-half of all U.S. adults with diabetes are not at recommended LDL-C or BP treatment goals.</p>

Abstract licence: CC BY-NC-ND

Cited by papers we hold1

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.